Pearl River Capital’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,871
Closed -$586K 483
2024
Q1
$586K Buy
17,871
+806
+5% +$25.7K 0.09% 279
2023
Q4
$564K Buy
+17,065
New +$483K 0.09% 293
2023
Q3
Sell
-11,869
Closed -$360K 532
2023
Q2
$360K Sell
11,869
-945
-7% -$30.6K 0.06% 370
2023
Q1
$416K Buy
12,814
+1,219
+11% +$38.5K 0.07% 355
2022
Q4
$326K Buy
+11,595
New +$332K 0.06% 398
2022
Q2
Sell
-6,377
Closed -$206K 478
2022
Q1
$206K Sell
6,377
-2,748
-30% -$72K 0.06% 363
2021
Q4
$252K Buy
+9,125
New +$262K 0.07% 335

Other funds holding EVH

Pearl River Capital's EVH Position: Q2 2024 in Review

Pearl River Capital sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 17,871 shares — an estimated $586K sold.

Pearl River Capital first reported a position in EVH in Q4 2021 and held it in 7 quarters. The position peaked at $586K in Q1 2024. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

  • Pearl River Capital reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
  • Pearl River Capital sold 17,871 Evolent Health shares in Q2 2024, an estimated $586K.
  • Pearl River Capital first reported a position in Evolent Health in Q4 2021 and held it in 7 quarters.
  • Pearl River Capital's Evolent Health position peaked at $586K in Q1 2024.
  • 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Pearl River Capital's 13F filing for Q2 2024, filed 13 Aug 2024.